Page last updated: 2024-08-25

rosiglitazone and Diabetic Neuropathies

rosiglitazone has been researched along with Diabetic Neuropathies in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gluch-Lutwin, M; Librowski, T; Nawiesniak, B; Sałat, K1
Patel, SS; Udayabanu, M1
Brosius, FC; Feldman, EL; Kretzler, M; Pennathur, S; Sullivan, KA; Wiggin, TD1
Abraira, C; Davis, SN; Duckworth, W; Emanuele, N; Goldman, S; Hayward, R; Henderson, WG; Huang, GD; Marks, J; McCarren, M; Moritz, T; Reaven, PD; Reda, D; Vitek, ME; Warren, SR; Zieve, FJ1
Rennings, AJ; Smits, P; Stewart, MW; Tack, CJ1

Trials

2 trial(s) available for rosiglitazone and Diabetic Neuropathies

ArticleYear
Glucose control and vascular complications in veterans with type 2 diabetes.
    The New England journal of medicine, 2009, Jan-08, Volume: 360, Issue:2

    Topics: Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Neuropathies; Drug Therapy, Combination; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Kaplan-Meier Estimate; Male; Metformin; Middle Aged; Rosiglitazone; Sulfonylurea Compounds; Thiazolidinediones; United States; Veterans

2009
Autonomic neuropathy predisposes to rosiglitazone-induced vascular leakage in insulin-treated patients with type 2 diabetes: a randomised, controlled trial on thiazolidinedione-induced vascular leakage.
    Diabetologia, 2010, Volume: 53, Issue:9

    Topics: Adult; Aged; Capillary Permeability; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Double-Blind Method; Female; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Rosiglitazone; Thiazolidinediones; Vasodilation

2010

Other Studies

3 other study(ies) available for rosiglitazone and Diabetic Neuropathies

ArticleYear
Evaluation of analgesic, antioxidant, cytotoxic and metabolic effects of pregabalin for the use in neuropathic pain.
    Neurological research, 2013, Volume: 35, Issue:9

    Topics: 3T3-L1 Cells; Analgesics; Animals; Antioxidants; Cell Death; Diabetes Mellitus, Experimental; Diabetic Neuropathies; gamma-Aminobutyric Acid; Glucose; Hep G2 Cells; Humans; Hyperalgesia; Lipid Metabolism; Male; Mice; Motor Skills; Neuralgia; Pain Threshold; Pregabalin; Rosiglitazone; Terfenadine; Thiazolidinediones

2013
Effect of Urtica dioica on memory dysfunction and hypoalgesia in an experimental model of diabetic neuropathy.
    Neuroscience letters, 2013, Sep-27, Volume: 552

    Topics: Animals; Avoidance Learning; Blood Glucose; Body Weight; Diabetic Neuropathies; Drug Therapy, Combination; Insulin; Maze Learning; Memory Disorders; Mice; Pain Threshold; Phytotherapy; Plant Extracts; Plant Leaves; Polydipsia; Rosiglitazone; Streptozocin; Thiazolidinediones; Urtica dioica

2013
Rosiglitazone treatment reduces diabetic neuropathy in streptozotocin-treated DBA/2J mice.
    Endocrinology, 2008, Volume: 149, Issue:10

    Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Female; Gene Expression; Genomics; Growth Hormone; Hyperalgesia; Hypoglycemic Agents; Male; Mice; Mice, Inbred DBA; Oligonucleotide Array Sequence Analysis; Oxidative Stress; Promoter Regions, Genetic; Rosiglitazone; Thiazolidinediones

2008